The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 8, 2010, Pages 558-566

  Junyent, M ^a   Tucker, K L ^a   Smith, C E ^a   Lane, J M ^a   Mattei, J ^a   Lai, C Q ^a   Parnell, L D ^a   Ordovas, J M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

ATP binding cassette transporters; Gene gene interaction; HDL cholesterol; Pathway; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABCG5 PROTEIN, HUMAN; ABCG8 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

AGED; ARTICLE; BLOOD; FEMALE; GENETIC EPISTASIS; GENETICS; HISPANIC; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; BOSTON; CHOLESTEROL, HDL; EPISTASIS, GENETIC; FEMALE; HISPANIC AMERICANS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77956727878     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.05.005     Document Type: Article

References (32)

1. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256:2835-2838.
2. Lewis G.F., Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232.
3. Naik S.U., Wang X., Da Silva J.S., Jaye M., Macphee C.H., Reilly M.P., et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006, 113:90-97.
4. Calpe-Berdiel L., Rotllan N., Fiévet C., Roig R., Blanco-Vaca F., Escola-Gil J.C. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ATP-binding cassette (ABC) G5/G8. J Lipid Res 2008, 49:1904-1911.
5. Hubacek J.A., Berge K.E., Cohen J.C., Hobbs H.H. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001, 18:359-360.
6. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 2002, 99:16237-16242.
7. Brunham L.R., Kruit J.K., Iqbal J., Fievet C., Timmins J.M., Pape T.D., et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 2006, 116:1052-1062.
8. Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation. Curr Opin Lipidol 2005, 16:19-25.
9. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345.
10. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 2000, 97:4245-4250.
11. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M., et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002, 110:35-42.
12. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002, 277:18793-18800.
13. Schwartz K., Lawn R.M., Wade D.P. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 2000, 274:794-802.
14. Cavelier L.B., Qiu Y., Bielicki J.K., Afzal V., Cheng J.F., Rubin E.M. Regulation and activity of the human ABCA1 gene in transgenic mice. J Biol Chem 2001, 276:18046-18051.
15. Plösch T., Kok T., Bloks V.W., Smit M.J., Havinga R., Chimini G., et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 2002, 277:33870-33877.
16. Singaraja R.R., Bocher V., James E.R., Clee S.M., Zhang L.H., Leavitt B.R., et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem 2001, 276:33969-33979.
17. Brunham L.R., Kruit J.K., Pape T.D., Parks J.S., Kuipers F., Hayden M.R. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ Res 2006, 99:672-674.
18. Beyer T.P., Schmidt R.J., Foxworthy P., Zhang Y., Dai J., Bensch W.R., et al. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. J Pharmacol Exp Ther 2004, 309:861-868.
19. Junyent M., Tucker K.L., Smith C.E., Garcia A., Mattei J., Lai C.Q., et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 2009, 50:1565-1573.
20. Lee I.M., Paffenbarger R.S. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 1998, 29:2049-2054.
21. Marinescu V.D., Kohane I.S., Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005, 6:79.
22. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999, 14:143-149.
23. Plat J., Bragt M.C., Mensink R.P. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J Lipid Res 2005, 46:68-75.
24. Gylling H., Hallikainen M., Pihlajamäki J., Agren J., Laakso M., Rajaratnam R.A., et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004, 45:1660-1665.
25. Miwa K., Inazu A., Kobayashi J., Higashikata T., Nohara A., Kawashiri M., et al. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. Clin Sci 2005, 109:183-188.
26. Acalovschi M., Ciocan A., Mostean O., Tirziu S., Chiorean E., Keppeler H., et al. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006, 17:490-494.
27. Wang Y., Jiang Z.Y., Fei J., Xin L., Cai Q., Jiang Z.H., et al. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin Chim Acta 2007, 384:80-85.
28. Jensen M.K., Pai J.K., Mukamal K.J., Overvad K., Rimm E.B. Common genetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk of coronary heart disease. Atherosclerosis 2007, 195:e172-e180.
29. Brunham L.R., Singaraja R.R., Hayden M.R. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr 2006, 26:105-129.
30. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003, 23:1322-1332.
31. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002, 22:630-637.
32. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002, 99:7604-7609.